Private choices, public costs: Evaluating cost-shifting between private and public health sectors in New Zealand.

Costs and cost analysis Inpatient New Zealand Patient readmission Private sector Public sector

Journal

Health policy (Amsterdam, Netherlands)
ISSN: 1872-6054
Titre abrégé: Health Policy
Pays: Ireland
ID NLM: 8409431

Informations de publication

Date de publication:
03 2021
Historique:
received: 13 08 2020
revised: 09 12 2020
accepted: 17 12 2020
pubmed: 7 1 2021
medline: 5 8 2021
entrez: 6 1 2021
Statut: ppublish

Résumé

New Zealand's dual public-private health system allows individuals to purchase health services from the private sector rather than relying solely upon publicly-funded services. However, financial boundaries between the public and private sectors are not well defined and patients receiving privately-funded care may subsequently seek follow-up care within the public health system, in effect shifting costs to the public sector. This study evaluates this phenomenon, examining whether cost-shifting between the private and public hospital systems is a significant issue in New Zealand. We used inpatient discharge data from 2013/14 to identify private events with a subsequent admission to a public hospital within seven days of discharge. We examined the frequency of subsequent public admissions, the demographic and clinical characteristics of the patients and estimated the direct costs of inpatient care incurred by the public health system. Approximately 2% of private inpatient events had a subsequent admission to a public hospital. Overall, the costs to the public system amounted to NZ$11.5 million, with a median cost of NZ$2800. At least a third of subsequent admissions were related to complications of a medical procedure. Although only a small proportion of private events had a subsequent public admission, the public health system incurred significant costs, highlighting the need for greater understanding and discussion around the interface between the public and private health systems.

Identifiants

pubmed: 33402263
pii: S0168-8510(20)30319-5
doi: 10.1016/j.healthpol.2020.12.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

406-414

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors report no declarations of interest.

Auteurs

Erin Penno (E)

Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand; Centre for Health Systems and Technology, University of Otago, New Zealand.

Trudy Sullivan (T)

Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand; Centre for Health Systems and Technology, University of Otago, New Zealand. Electronic address: trudy.sullivan@otago.ac.nz.

Dave Barson (D)

Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand.

Robin Gauld (R)

Centre for Health Systems and Technology, University of Otago, New Zealand; Otago Business School, University of Otago, Dunedin, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH